Lv4
590 积分 2026-01-04 加入
Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B
28天前
已完结
Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis
1个月前
已完结
Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection
1个月前
已完结
Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B
1个月前
已完结
Characteristics and immune dynamics of peripheral blood immune cells and cytokines in individuals with chronic hepatitis B virus infection
5个月前
已完结
Circulating Cell‐Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV‐Related Acute‐on‐Chronic Liver Failure
5个月前
已完结
Hepatitis B: Part II. Updates on Diagnosis and Therapy
6个月前
已关闭
‘What is new in hepatitis B’
6个月前
已关闭
Increased risk of HCC in HBeAg-negative indeterminate phase compared with HBeAg-negative chronic infection
6个月前
已完结
Differential HCC risk among HBV indeterminate types at baseline and by phase transition
6个月前
已关闭
皖公网安备34019202002308
